Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement of aortic exposure by superior vena cava snaring and traction during lower partial sternotomy.

Indian journal of thoracic and cardiovascular surgery·2025
Same author

The effect of levosimendan on the right ventricular function in patients with right ventricular dysfunction undergoing mitral valve surgery.

Annals of cardiac anaesthesia·2023
Same author

PROSE: Prospective Randomized Trial of the On-X Mechanical Prosthesis and the St Jude Medical Mechanical Prosthesis Evaluation: Part 2: Study results-prostheses, positions, and economic development.

JTCVS open·2023
Same author

Inadequate response to adenosine infusion during cardiac stress magnetic resonance imaging.

Annals of cardiac anaesthesia·2022
Same author

Toward the development of a polarimetric tool to diagnose the fibrotic human ventricular myocardium.

Journal of biomedical optics·2022
Same author

Rheumatic Heart Disease in India in 2020: Advances in Diagnostic and Therapeutic Options.

The Journal of the Association of Physicians of India·2022
Same journal

A Systematic Review on the Impact of Postoperative Rehabilitation Programs in Thoracic Surgery Patients.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Endoscopic vs. Operative Management of Acute Esophageal Perforation: A 21-Year Experience at a High-Volume Referral Center.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Valved Sano Conduit During the Norwood Procedure: A Contemporary Review of Early Outcomes, Reintervention Burden, and Pulmonary Artery Growth.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Propensity Score-Matched Analysis Comparing Modified Konno Procedure and Transaortic Septal Myectomy in Children With Left Ventricular Outflow Tract Obstruction.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Post-Operative Hemothorax: Uniportal Video-Assisted Thoracic Surgery vs Thoracotomy-Analysis of Outcomes and Costs.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Palliative Care Throughout the Entire Perioperative Pathway in Cardiovascular Surgery.

Seminars in thoracic and cardiovascular surgery·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Myocardial preservation: controlled reperfusion.

Prasanna Simha Mohan Rao1, Parimala Prasanna Simha

  • 1Department of Cardiothoracic and Vascular Surgery, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, Karnataka, India. prasannasimha@gmail.com

Seminars in Thoracic and Cardiovascular Surgery
|March 27, 2012
PubMed
Summary
This summary is machine-generated.

Reperfusion injury after cardiac surgery can be reduced by controlling the reperfusion environment. Optimizing warm reperfusate composition and flow helps protect the heart from ischemic damage.

More Related Videos

Model of Ischemia and Reperfusion Injury in Rabbits
06:11

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Experiment Videos

Last Updated: May 23, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Model of Ischemia and Reperfusion Injury in Rabbits
06:11

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia
  • Myocardial Protection

Background:

  • Reperfusion injury is a significant complication following cardiac surgery.
  • Restoring coronary blood flow after aortic cross-clamp release can paradoxically worsen myocardial damage.
  • This injury contributes to morbidity and mortality in cardiac surgery patients.

Purpose of the Study:

  • To investigate methods for attenuating reperfusion injury after cardiac surgery.
  • To explore the role of controlling the biochemical and physical environment during reperfusion.
  • To reduce myocardial damage and improve outcomes following cardioplegic arrest.

Main Methods:

  • Utilizing a warm reperfusate solution.
  • Administering drugs known to mitigate reperfusion injury.
  • Manipulating coronary vascular resistance and physical reperfusion parameters.

Main Results:

  • Controlled reperfusion strategies can decrease myocardial damage.
  • Optimizing reperfusate temperature and composition is beneficial.
  • Targeted manipulation of flow dynamics aids in myocardial recovery.

Conclusions:

  • Controlling the reperfusion environment is crucial for minimizing post-cardiac surgery injury.
  • Warm reperfusate and pharmacologic agents can significantly attenuate reperfusion-induced harm.
  • This approach aids in reestablishing coronary perfusion while protecting the heart from ischemia.